Lisinopril
Zestril, Prinivil
Also known as: Sinemet, Levodopa, Carbidopa Levodopa, Carbidopa/levodopa, Rytary, Duopa
Dopaminergic therapy for Parkinson's disease, an indication this clinic treats. ABRUPT WITHDRAWAL CAN PRECIPITATE A PARKINSONISM-HYPERPYREXIA (neuroleptic-malignant-like) SYNDROME, which is a medical emergency — the danger here is stopping the drug, not continuing it. Levodopa can also cause orthostatic hypotension, additive with ibogaine's.
Severity
Major risk
Mechanism
Other clinical interaction
Protocol Status
Continue as prescribed — cleared by a measured lab value, not a waiting period
Restart Delay
Physician discretion
What "Major risk" Means
Serious clinical risk requiring physician-led tapering, washout, and monitoring. Treatment may proceed once the medication is appropriately cleared or transitioned.
Clinical Action
NEVER interrupt or delay scheduled doses on our initiative, including during the acute phase; missed doses are the hazard. Any change belongs to the treating neurologist. Monitor blood pressure and take orthostatic precautions.
Where the Washout Happens
Continue as prescribed — cleared by a measured lab value, not a waiting period
This medication is not stopped for treatment, and should not be stopped on our initiative — the condition it treats usually outranks the interaction. What it changes is monitoring: serum potassium and magnesium are measured before the flood dose and corrected to target, and the dose is deferred until those numbers are right rather than until a number of days have passed. Any change to the prescription belongs to the prescribing physician.
Post-Treatment Restart
Restart at physician discretion once acute window closes.
The Pharmacology
This class has clinical considerations that do not fit a single mechanism category. Review the specific risk and clinical action for handling, and discuss with the prescribing physician.
Same Mechanism
Same Severity Tier
Opioid receptor potentiation
Methadose, Dolophine
Opioid receptor potentiation
Suboxone, Subutex
Opioid receptor potentiation
Duragesic, Sublimaze
Opioid receptor potentiation
Oxycontin, Percocet
Opioid receptor potentiation
Vicodin, Norco
Opioid receptor potentiation
Ms Contin, Kadian
Common Questions
Major risk. Dopaminergic therapy for Parkinson's disease, an indication this clinic treats. ABRUPT WITHDRAWAL CAN PRECIPITATE A PARKINSONISM-HYPERPYREXIA (neuroleptic-malignant-like) SYNDROME, which is a medical emergency — the danger here is stopping the drug, not continuing it. Levodopa can also cause orthostatic hypotension, additive with ibogaine's. NEVER interrupt or delay scheduled doses on our initiative, including during the acute phase; missed doses are the hazard. Any change belongs to the treating neurologist. Monitor blood pressure and take orthostatic precautions.
Continue as prescribed — cleared by a measured lab value, not a waiting period. This medication is not stopped for treatment, and should not be stopped on our initiative — the condition it treats usually outranks the interaction. What it changes is monitoring: serum potassium and magnesium are measured before the flood dose and corrected to target, and the dose is deferred until those numbers are right rather than until a number of days have passed. Any change to the prescription belongs to the prescribing physician.
Other clinical interaction. This class has clinical considerations that do not fit a single mechanism category. Review the specific risk and clinical action for handling, and discuss with the prescribing physician.
In many cases yes. Our medical team works with your prescribing physician to taper or substitute medications safely before treatment. The right substitution depends on the underlying condition you are treating with Carbidopa-Levodopa — contact us for an individual review.
Checking more than one medication? Use the interactive Drug Interaction Checker to screen your full medication list at once.
Browse all 145 medications in the A–Z directory.